Apolipoprotein (a) phenotypes and lipoprotein (a) concentrations in patients with type III hyperlipoproteinaemia

Abstract. Objectives. The familial lipoprotein disorder type III hyperlipoproteinaemia (HLP) carries a marked increase in the risk of accelerated and premature atherosclerosis, but there is considerable variation amongst affected individuals in their susceptibility to cardiovascular disease (CVD). T...

Full description

Saved in:
Bibliographic Details
Main Authors: Feussner, Giso (Author) , Feussner, Vera (Author) , Ziegler, Reinhard (Author)
Format: Article (Journal)
Language:English
Published: May 1994
In: Journal of internal medicine
Year: 1994, Volume: 235, Issue: 5, Pages: 425-430
ISSN:1365-2796
DOI:10.1111/j.1365-2796.1994.tb01098.x
Online Access:Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1111/j.1365-2796.1994.tb01098.x
Verlag, lizenzpflichtig, Volltext: https://onlinelibrary.wiley.com/doi/abs/10.1111/j.1365-2796.1994.tb01098.x
Get full text
Author Notes:G. Feussner, V. Feussner, R. Ziegler

MARC

LEADER 00000caa a2200000 c 4500
001 1915996686
003 DE-627
005 20250716225415.0
007 cr uuu---uuuuu
008 250130s1994 xx |||||o 00| ||eng c
024 7 |a 10.1111/j.1365-2796.1994.tb01098.x  |2 doi 
035 |a (DE-627)1915996686 
035 |a (DE-599)KXP1915996686 
035 |a (OCoLC)1528018226 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 33  |2 sdnb 
100 1 |a Feussner, Giso  |e VerfasserIn  |0 (DE-588)1111522685  |0 (DE-627)865591776  |0 (DE-576)476134900  |4 aut 
245 1 0 |a Apolipoprotein (a) phenotypes and lipoprotein (a) concentrations in patients with type III hyperlipoproteinaemia  |c G. Feussner, V. Feussner, R. Ziegler 
264 1 |c May 1994 
300 |a 6 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Gesehen am 30.01.2025 
520 |a Abstract. Objectives. The familial lipoprotein disorder type III hyperlipoproteinaemia (HLP) carries a marked increase in the risk of accelerated and premature atherosclerosis, but there is considerable variation amongst affected individuals in their susceptibility to cardiovascular disease (CVD). Therefore, it was the aim of our study to investigate the possible influence of lipoprotein (a) [Lp(a)] in the pathogenesis of type III HLP. Design. Apolipoprotein (a) [apo(a)] phenotypes and Lp(a) concentrations were determined in patients with the disease and in an appropriate control group. Setting. University out-patient lipid disorder clinic. Subjects. Seventy-six apoE-2 homozygous patients with type III HLP and 76 normolipidaemic and healthy age- and sex-matched controls. Main outcome measures. The frequencies of different apo(a) phenotypes and their correlations with Lp(a) serum concentrations were determined in patients and controls. Results. Lp(a) concentrations were not significantly different in type III HLP patients (14.1±19.1 mg dl-1) as compared with the controls (13.3±16.2 mg dl-1; P = 0.549, NS). In addition, there was no significant difference in apo(a) phenotype frequencies amongst both groups (0.2 > P > 0.1). Conclusions. We conclude that the apo(a) polymorphism does not participate (to a significant extent) in the phenotypical expression of type III HLP. 
650 4 |a apolipoprotein (a) 
650 4 |a atherosclerosis 
650 4 |a familial dysbetalipoproteinaemia 
650 4 |a lipoprotein (a) 
650 4 |a type III hyperlipoproteinaemia 
700 1 |a Feussner, Vera  |e VerfasserIn  |0 (DE-588)1129818616  |0 (DE-627)884421988  |0 (DE-576)174782500  |4 aut 
700 1 |a Ziegler, Reinhard  |d 1935-  |e VerfasserIn  |0 (DE-588)115545344  |0 (DE-627)077320182  |0 (DE-576)289941652  |4 aut 
773 0 8 |i Enthalten in  |t Journal of internal medicine  |d Oxford [u.a.] : Wiley-Blackwell, 1863  |g 235(1994), 5, Seite 425-430  |h Online-Ressource  |w (DE-627)320457826  |w (DE-600)2006883-9  |w (DE-576)091142881  |x 1365-2796  |7 nnas  |a Apolipoprotein (a) phenotypes and lipoprotein (a) concentrations in patients with type III hyperlipoproteinaemia 
773 1 8 |g volume:235  |g year:1994  |g number:5  |g pages:425-430  |g extent:6  |a Apolipoprotein (a) phenotypes and lipoprotein (a) concentrations in patients with type III hyperlipoproteinaemia 
856 4 0 |u https://doi.org/10.1111/j.1365-2796.1994.tb01098.x  |x Verlag  |x Resolving-System  |z lizenzpflichtig  |3 Volltext 
856 4 0 |u https://onlinelibrary.wiley.com/doi/abs/10.1111/j.1365-2796.1994.tb01098.x  |x Verlag  |z lizenzpflichtig  |3 Volltext 
951 |a AR 
992 |a 20250130 
993 |a Article 
994 |a 1994 
998 |g 115545344  |a Ziegler, Reinhard  |m 115545344:Ziegler, Reinhard  |d 910000  |d 910100  |e 910000PZ115545344  |e 910100PZ115545344  |k 0/910000/  |k 1/910000/910100/  |p 3  |y j 
998 |g 1129818616  |a Feussner, Vera  |m 1129818616:Feussner, Vera  |d 50000  |e 50000PF1129818616  |k 0/50000/  |p 2 
998 |g 1111522685  |a Feussner, Giso  |m 1111522685:Feussner, Giso  |d 910000  |d 910100  |e 910000PF1111522685  |e 910100PF1111522685  |k 0/910000/  |k 1/910000/910100/  |p 1  |x j 
999 |a KXP-PPN1915996686  |e 4659238601 
BIB |a Y 
SER |a journal 
JSO |a {"type":{"bibl":"article-journal","media":"Online-Ressource"},"title":[{"title_sort":"Apolipoprotein (a) phenotypes and lipoprotein (a) concentrations in patients with type III hyperlipoproteinaemia","title":"Apolipoprotein (a) phenotypes and lipoprotein (a) concentrations in patients with type III hyperlipoproteinaemia"}],"relHost":[{"type":{"bibl":"periodical","media":"Online-Ressource"},"part":{"year":"1994","issue":"5","text":"235(1994), 5, Seite 425-430","pages":"425-430","extent":"6","volume":"235"},"disp":"Apolipoprotein (a) phenotypes and lipoprotein (a) concentrations in patients with type III hyperlipoproteinaemiaJournal of internal medicine","language":["eng"],"titleAlt":[{"title":"Medicinskt archiv"},{"title":"Nordiskt medicinskt arkiv"},{"title":"Acta medica Scandinavica"}],"title":[{"title_sort":"Journal of internal medicine","title":"Journal of internal medicine"}],"origin":[{"dateIssuedDisp":"1863-","publisherPlace":"Oxford [u.a.] ; Oxford [u.a.] ; Oxford [u.a.]","dateIssuedKey":"1863","publisher":"Wiley-Blackwell ; Blackwell Science ; Blackwell"}],"physDesc":[{"extent":"Online-Ressource"}],"note":["Gesehen am 08.04.22"],"pubHistory":["1.1863 - 4.1868; [N.F.] 1.1869 -"],"id":{"eki":["320457826"],"doi":["10.1111/(ISSN)1365-2796"],"issn":["1365-2796"],"zdb":["2006883-9"]},"recId":"320457826"}],"origin":[{"dateIssuedDisp":"May 1994","dateIssuedKey":"1994"}],"language":["eng"],"physDesc":[{"extent":"6 S."}],"note":["Gesehen am 30.01.2025"],"person":[{"given":"Giso","family":"Feussner","display":"Feussner, Giso","role":"aut","roleDisplay":"VerfasserIn"},{"given":"Vera","family":"Feussner","roleDisplay":"VerfasserIn","display":"Feussner, Vera","role":"aut"},{"roleDisplay":"VerfasserIn","display":"Ziegler, Reinhard","role":"aut","family":"Ziegler","given":"Reinhard"}],"name":{"displayForm":["G. Feussner, V. Feussner, R. Ziegler"]},"id":{"doi":["10.1111/j.1365-2796.1994.tb01098.x"],"eki":["1915996686"]},"recId":"1915996686"} 
SRT |a FEUSSNERGIAPOLIPOPRO1994